LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.39 | 17.25 | 2040 | 4141 | 0.4926 | 0.8287 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.39 | 17.25 | 2201 | 4141 | 0.5314 | 0.8463 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.39 | 17.25 | 1752 | 4141 | 0.4230 | 0.7938 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.39 | 17.25 | 2311 | 4141 | 0.5580 | 0.8578 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.36 | 17.25 | 2202 | 4390 | 0.5016 | 0.8346 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.36 | 17.25 | 2346 | 4390 | 0.5344 | 0.8492 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.36 | 17.25 | 2116 | 4390 | 0.4820 | 0.8254 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.36 | 17.25 | 2451 | 4390 | 0.5583 | 0.8593 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.33 | 17.25 | 2350 | 4651 | 0.5053 | 0.8379 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.33 | 17.25 | 2484 | 4651 | 0.5341 | 0.8505 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.33 | 17.25 | 2311 | 4651 | 0.4969 | 0.8341 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.33 | 17.25 | 2630 | 4651 | 0.5655 | 0.8637 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.30 | 17.25 | 2518 | 4798 | 0.5247 | 0.8473 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.30 | 17.25 | 2648 | 4798 | 0.5518 | 0.8588 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.30 | 17.25 | 2202 | 4798 | 0.4589 | 0.8171 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.30 | 17.25 | 2787 | 4798 | 0.5808 | 0.8705 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.27 | 17.25 | 2684 | 4884 | 0.5495 | 0.8583 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.27 | 17.25 | 2834 | 4884 | 0.5803 | 0.8707 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.27 | 17.25 | 2736 | 4884 | 0.5602 | 0.8627 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.27 | 17.25 | 2996 | 4884 | 0.6134 | 0.8835 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.24 | 17.25 | 2749 | 4929 | 0.5577 | 0.8619 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.24 | 17.25 | 2956 | 4929 | 0.5997 | 0.8785 | MN20160310_N02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.24 | 17.25 | 2811 | 4929 | 0.5703 | 0.8670 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.24 | 17.25 | 3140 | 4929 | 0.6370 | 0.8925 | MN20160310_N02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.21 | 17.25 | 2897 | 4942 | 0.5862 | 0.8733 | MN20160310_N02 | L07 |